Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.

There is no licensed treatment for non-alcoholic fatty liver disease (NAFLD), a condition that increases risk of chronic liver disease, type 2 diabetes and cardiovascular disease. We tested whether 15-18 months treatment with docosahexaenoic acid (DHA) plus eicosapentaenoic acid (EPA) (Omacor/Lovaza...

書目詳細資料
Main Authors:	Scorletti, E, Bhatia, L, McCormick, K, Clough, G, Nash, K, Hodson, L, Moyses, H, Calder, P, Byrne, C
格式:	Journal article
語言:	English
出版:	2014

相似書籍

Potential benefits of purified long chain omega-3 fatty acid treatment in non-alcoholic fatty liver disease (NAFLD): a potential treatment for early NAFLD in metabolic syndrome and Type 2 diabetes? Results from the WELCOME study
由: Scorletti, E, et al.
出版: (2014)

Whole-body and hepatic dietary fatty acid oxidation is related to postprandial insulin concentrations in people with non-alcoholic fatty liver disease with varying degrees of insulin resistance
由: Hodson, L, et al.
出版: (2013)

Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study
由: Hodson, L, et al.
出版: (2017)

Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
由: Fraser D. Russell, et al.
出版: (2012-11-01)

Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic Acids
由: Safi U. Khan, MD, MS, et al.
出版: (2021-09-01)

The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials
由: Gyu Yeong Choi, et al.
出版: (2024-09-01)

Alterations in serum phosphatidylcholine fatty acyl species by eicosapentaenoic and docosahexaenoic ethyl esters in patients with severe hypertriglyceridemia
由: B J McKeone, et al.
出版: (1997-03-01)

Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis
由: Geraldine F. Clough, et al.
出版: (2020-06-01)

Obtention of highly purified fractions of eicosapentaenoic acid and docosahexaenoic acid from sardine oil by silver-resin chromatography. A semipreparative procedure.
由: S. Nieto, et al.
出版: (1997-08-01)

Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation
由: Lise Madsen, et al.
出版: (1998-03-01)

Eicosapentaenoic Acid and Docosahexaenoic Acid in Endurance Performance and Cardiovascular Function
由: Eisuke Ochi, et al.
出版: (2019-11-01)

Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells
由: Salmona Mario, et al.
出版: (2008-09-01)

Comparison and validation of a fast method for the extraction and quantification of α-linolenic, eicosapentaenoic, and docosahexaenoic fatty acids
由: Alejandro OVIEDO CASTRILLÓN, et al.
出版: (2016-12-01)

Comparison and validation of a fast method for the extraction and quantification of α-Linolenic, Eicosapentaenoic, and Docosahexaenoic fatty acids
由: Alejandro Oviedo-Castrillón, et al.

Fatty Acid Taste Receptor GPR120 Activation by Arachidonic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid in Chickens
由: Fuminori Kawabata, et al.
出版: (2022-07-01)

Eicosapentaenoic acid and docosahexaenoic acid suppress colonic tumorigenesis in obese mice
由: Yan Xu, et al.
出版: (2024-05-01)

Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids[S]
由: Christophe Morisseau, et al.
出版: (2010-12-01)

Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
由: Noriko Suzuki-Kemuriyama, et al.
出版: (2016-01-01)

Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.
由: Valerio Nobili, et al.
出版: (2014-01-01)

Dietary Docosahexaenoic Acid and Eicosapentaenoic Acid Influence Liver Triacylglycerol and Insulin Resistance in Rats Fed a High-Fructose Diet
由: Gabriela Salim de Castro, et al.
出版: (2015-04-01)

Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish.
由: Browning, L, et al.
出版: (2012)

IMPACT OF DIETARY EICOSAPENTAENOIC AND DOCOSAHEXAENOIC FATTY ACIDS SUPPLEMENTATION ON INFLAMMATORY RESPONSE OF POST CALVING COWS DURING TRANSITION TO LACTATION
由: Shaimaa Elbaz, et al.
出版: (2019-03-01)

Differential impact of eicosapentaenoic acid and docosahexaenoic acid in an animal model of Alzheimer’s disease
由: Méryl-Farelle Oye Mintsa Mi-mba, et al.
出版: (2024-12-01)

Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)—Should They Be Mandatory Supplements in Pregnancy?
由: Mihaela Amza, et al.
出版: (2024-07-01)

The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis
由: Aslıhan Avanoǧlu Güler, et al.
出版: (2020-06-01)

Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammation and oxidative stress
由: Schilling Brian, et al.
出版: (2009-07-01)

Compared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans.
由: Browning, L, et al.
出版: (2014)

Dietary docosahexaenoic acid (DHA) downregulates liver DHA synthesis by inhibiting eicosapentaenoic acid elongation
由: Adam H. Metherel, et al.
出版: (2024-06-01)

Selective Consumption of Fish Oil at End of the Day Increases the Physiological Fatty Acid Compositions of Eicosapentaenoic Acid and Docosahexaenoic Acid in Mice
由: Hiroki Matsuzaka, et al.
出版: (2022-02-01)

Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
由: Angélica Borja-Magno, et al.
出版: (2023-05-01)

Quantitation of alpha-linolenic acid elongation to eicosapentaenoic and docosahexaenoic acid as affected by the ratio of n6/n3 fatty acids
由: Somoza Veronika, et al.
出版: (2009-02-01)

Plasma Docosahexaenoic Acid and Eicosapentaenoic Acid Concentrations Are Positively Associated with Brown Adipose Tissue Activity in Humans
由: Angie S. Xiang, et al.
出版: (2020-09-01)

Effect of Dietary Eicosapentaenoic and Docosahexaenoic Fatty Acid Supplementation during the Last Month of Gestation on Fatty Acid Metabolism and Oxidative Status in Charolais Cows and Calves
由: Diana Brozić, et al.
出版: (2024-04-01)

Stability of eicosapentaenoic acid and docosahexaenoic acid in spray-dried powder of emulsified krill oil
由: Afroza Sultana, et al.
出版: (2021-06-01)

Eicosapentaenoic and docosahexaenoic acids as inflammation-modulating and lipid homeostasis influencing nutraceuticals: A review
由: Tomáš Komprda
出版: (2012-01-01)

Oxidative stability of eicosapentaenoic acid and docosahexaenoic acid in krill oil microencapsulated by spray drying
由: Afroza Sultana, et al.
出版: (2021-01-01)

Docosahexaenoic acid, but not eicosapentaenoic acid, improves septic shock-induced arterial dysfunction in rats.
由: Alexandra Boivin, et al.
出版: (2017-01-01)

Dietary carbohydrates and fats in nonalcoholic fatty liver disease
由: Yki-Järvinen, H, et al.
出版: (2021)

Omega-3 Polyunsaturated Fatty Acid Eicosapentaenoic Acid or Docosahexaenoic Acid Improved Ageing-Associated Cognitive Decline by Regulating Glial Polarization
由: Juan Xia, et al.
出版: (2023-07-01)

Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review
由: Cristian Sandoval, et al.
出版: (2023-11-01)